SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-022221
Filing Date
2020-02-03
Accepted
2020-02-03 07:40:11
Documents
18
Period of Report
2020-02-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d881893d8k.htm   iXBRL 8-K 47336
2 EX-2.1 d881893dex21.htm EX-2.1 497719
3 EX-99.1 d881893dex991.htm EX-99.1 250079
4 EX-99.2 d881893dex992.htm EX-99.2 22455
8 GRAPHIC g881893g0203025609376.jpg GRAPHIC 2084
9 GRAPHIC g881893g0203030615190.jpg GRAPHIC 4301
10 GRAPHIC g881893img001.jpg GRAPHIC 2951
  Complete submission text file 0001193125-20-022221.txt   1103878

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ctlt-20200202.xsd EX-101.SCH 3057
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctlt-20200202_lab.xml EX-101.LAB 17373
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctlt-20200202_pre.xml EX-101.PRE 10944
18 EXTRACTED XBRL INSTANCE DOCUMENT d881893d8k_htm.xml XML 3222
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Filer) CIK: 0001596783 (see all company filings)

IRS No.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36587 | Film No.: 20566982
SIC: 2834 Pharmaceutical Preparations